US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist
  • 3.5000
  • -0.1000-2.78%
Trading Jul 31 11:20 ET
2.92MMarket Cap-3P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ZyVersa Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-4.53

+96.67%
Analyst Rating

No Data

ZyVersa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

ZyVersa Therapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 15 08:35 ET

  • 10-K/A: Annual report (Amendment)

    May 15 08:30 ET

  • ZyVersa Therapeutics | 10-K: Annual report

    Mar 25 08:03 ET

  • ZyVersa Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg